# Beam Therapeutics Inc.: Form D filings

Beam Therapeutics Inc., a pharmaceuticals company in Cambridge, MA, filed 3 Form D notices with the SEC between 2018 and 2019. The latest, on March 26, 2019, reports $135 million sold of a $135 million offering to 27 investors.

Find out what Beam Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Beam%20Therapeutics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Beam%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbeam-therapeutics-inc-1745999)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Beam%20Therapeutics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Beam%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbeam-therapeutics-inc-1745999)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 26 LANDSDOWNE STREET, Cambridge, MA, 02139
- Phone: (857) 327-8775
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1745999

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 26, 2019 | New notice | $135,000,002 | $135,000,002 | $0 | 27 | Nov 8, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1745999/000174599919000002/0001745999-19-000002-index.htm) |
| Mar 26, 2019 | Amendment | $83,573,967 | $83,573,967 | $0 | 21 | Feb 9, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1745999/000174599919000001/0001745999-19-000001-index.htm) |
| Aug 9, 2018 | New notice | Indefinite | $44,999,981 | Indefinite | 20 | Feb 9, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1745999/000174599918000001/0001745999-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| CAROLE HO | Director |  |
| STEPHEN KNIGHT | Director |  |
| KRISTINA BUROW | Director |  |
| JOHN EVANS | Executive Officer, Director |  |
| MARK FISHMAN | Director |  |
| MICHAEL YI | Director |  |
| ROBERT NELSEN | Director |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Mar 25, 2019](https://specstream.ai/data/form-d/week/2019-03-25) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Beam Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).